Published in Am J Physiol Regul Integr Comp Physiol on September 29, 2010
Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina. Proc Natl Acad Sci U S A (2013) 1.36
Glucose-induced posttranslational activation of protein phosphatases PP2A and PP1 in yeast. Cell Res (2012) 1.04
Diabetes and retinal vascular dysfunction. J Ophthalmic Vis Res (2015) 0.98
Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes. Circ Res (2016) 0.92
Retinoic acid protects cardiomyocytes from high glucose-induced apoptosis through inhibition of NF-κB signaling pathway. J Cell Physiol (2013) 0.89
High glucose exposure promotes activation of protein phosphatase 2A in rodent islets and INS-1 832/13 β-cells by increasing the posttranslational carboxylmethylation of its catalytic subunit. Endocrinology (2013) 0.80
DMH1 increases glucose metabolism through activating Akt in L6 rat skeletal muscle cells. PLoS One (2014) 0.78
Ceramide-Initiated Protein Phosphatase 2A Activation Contributes to Arterial Dysfunction In Vivo. Diabetes (2015) 0.78
Photoreceptor Cells Influence Retinal Vascular Degeneration in Mouse Models of Retinal Degeneration and Diabetes. Invest Ophthalmol Vis Sci (2016) 0.75
Knockdown of GSK3β increases basal autophagy and AMPK signalling in nutrient-laden human aortic endothelial cells. Biosci Rep (2016) 0.75
The association between Salt-inducible kinase 2 (SIK2) and gamma isoform of the regulatory subunit B55 of PP2A (B55gamma) contributes to the survival of glioma cells under glucose depletion through inhibiting the phosphorylation of S6K. Cancer Cell Int (2015) 0.75
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature (2000) 12.33
Signaling--2000 and beyond. Cell (2000) 11.78
The structure and regulation of protein phosphatases. Annu Rev Biochem (1989) 11.46
Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res (2007) 3.67
Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc Natl Acad Sci U S A (2003) 3.27
Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes (2006) 2.85
Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med (2003) 2.61
Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity. J Biol Chem (2004) 2.29
Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med (2003) 2.20
JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J Cell Biol (2005) 2.06
Lucigenin chemiluminescence in the assessment of neutrophil superoxide production. J Immunol Methods (1987) 1.83
Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol (1996) 1.66
Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem (2002) 1.65
Bad targets the permeability transition pore independent of Bax or Bak to switch between Ca2+-dependent cell survival and death. Mol Cell (2009) 1.58
Phosphorylation of NF-kappaB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination. EMBO Rep (2009) 1.54
Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A. FEBS Lett (1997) 1.53
Methylated C-terminal leucine residue of PP2A catalytic subunit is important for binding of regulatory Balpha subunit. Biochem J (1999) 1.48
Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. Biochem Pharmacol (2000) 1.43
The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo. J Biol Chem (1994) 1.42
PP2A regulates the pro-apoptotic activity of FOXO1. J Biol Chem (2008) 1.36
Protein phosphatase 2A: who shall regulate the regulator? Biochem Pharmacol (1999) 1.36
Selection of protein phosphatase 2A regulatory subunits is mediated by the C terminus of the catalytic Subunit. J Biol Chem (2007) 1.35
AIP1 recruits phosphatase PP2A to ASK1 in tumor necrosis factor-induced ASK1-JNK activation. Circ Res (2008) 1.23
Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin. FASEB J (2002) 1.22
Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway. Life Sci (2008) 1.22
High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway. Arterioscler Thromb Vasc Biol (2005) 1.22
Phosphorylation of serine 68 in the IkappaB kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-kappaB activity. J Biol Chem (2007) 1.19
Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway. Diabetologia (2008) 1.15
Hypoxia potentiates nitric oxide-mediated apoptosis in endothelial cells via peroxynitrite-induced activation of mitochondria-dependent and -independent pathways. J Biol Chem (2003) 1.13
Positive regulation of IkappaB kinase signaling by protein serine/threonine phosphatase 2A. J Biol Chem (2005) 1.13
Identification of PP2A as a crucial regulator of the NF-kappaB feedback loop: its inhibition by UVB turns NF-kappaB into a pro-apoptotic factor. Cell Death Differ (2008) 1.12
Protein phosphatase 2A regulates bim expression via the Akt/FKHRL1 signaling pathway in amyloid-beta peptide-induced cerebrovascular endothelial cell death. J Neurosci (2006) 1.09
Role of protein phosphatase 2A in the regulation of endothelial cell cytoskeleton structure. J Cell Biochem (2006) 1.07
Immunological evidence for methylglyoxal-derived modifications in vivo. Determination of antigenic epitopes. J Biol Chem (1998) 1.05
Carboxylmethylation of the catalytic subunit of protein phosphatase 2A in insulin-secreting cells: evidence for functional consequences on enzyme activity and insulin secretion. Endocrinology (1996) 1.02
Activation of a PP2A-like phosphatase and dephosphorylation of tau protein characterize onset of the execution phase of apoptosis. J Cell Sci (1998) 1.01
Apoptosis signal-regulating kinase 1 in amyloid beta peptide-induced cerebral endothelial cell apoptosis. J Neurosci (2007) 0.99
Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke (1994) 0.99
Spatial control of protein phosphatase 2A (de)methylation. Exp Cell Res (2007) 0.97
Prevention of endotoxin-induced uveitis in rats by benfotiamine, a lipophilic analogue of vitamin B1. Invest Ophthalmol Vis Sci (2009) 0.96
PP2A activity is controlled by methylation and regulates oncoprotein expression in melanoma cells: a mechanism which participates in growth inhibition induced by chloroethylnitrosourea treatment. Int J Oncol (2008) 0.95
Early atherosclerosis and vascular inflammation in mice with diet-induced type 2 diabetes. Eur J Clin Invest (2009) 0.92
Ischemic injury induces brain glucose transporter gene expression. Endocrinology (1993) 0.91
Novel regulatory roles for protein phosphatase-2A in the islet beta cell. Biochem Pharmacol (2005) 0.90
Hypertension increases retinal inflammation in experimental diabetes: a possible mechanism for aggravation of diabetic retinopathy by hypertension. Curr Eye Res (2007) 0.87
PPARalpha and PP2A are involved in the proapoptotic effect of conjugated linoleic acid on human hepatoma cell line SK-HEP-1. Int J Cancer (2007) 0.85
Regulation by glucose and calcium of the carboxylmethylation of the catalytic subunit of protein phosphatase 2A in insulin-secreting INS-1 cells. Am J Physiol Endocrinol Metab (2004) 0.84
Role of S-adenosylhomocysteine hydrolase in adenosine-induced apoptosis in HepG2 cells. Exp Cell Res (2006) 0.84
Phosphatases and regulation of cell death. Methods Enzymol (2008) 0.83
Hyperosmolarity causes inflammation through the methylation of protein phosphatase 2A. Inflamm Res (2008) 0.82
Okadaic acid enhances prostaglandin E1-induced alkaline phosphatase activity in osteoblast-like cells: regulation at a point downstream from protein kinase A. Prostaglandins Leukot Essent Fatty Acids (1996) 0.76
Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest (1996) 3.81
Progression of incipient diabetic retinopathy during good glycemic control. Diabetes (1987) 3.30
Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science (1996) 2.80
Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes (2001) 2.30
Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med (2003) 2.20
Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia (2007) 2.06
Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes (1994) 1.75
Retinopathy in animal models of diabetes. Diabetes Metab Rev (1995) 1.73
Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem (2002) 1.65
Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Diabetes (1993) 1.61
Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. Am J Physiol Regul Integr Comp Physiol (2004) 1.37
Experimental galactosemia produces diabetic-like retinopathy. Diabetes (1984) 1.33
Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Radic Biol Med (1997) 1.29
Retinal glutamate in diabetes and effect of antioxidants. Neurochem Int (2001) 1.27
Subnormal retinal oxygenation response precedes diabetic-like retinopathy. Invest Ophthalmol Vis Sci (1999) 1.18
Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia. Arch Ophthalmol (1995) 1.11
Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine. Curr Eye Res (2000) 1.10
Modulation of insulin secretion from normal rat islets by inhibitors of the post-translational modifications of GTP-binding proteins. Biochem J (1993) 1.08
Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes (1996) 1.07
Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model. Diabetologia (2012) 1.03
Reversible sodium pump defect and swelling in the diabetic rat erythrocyte: effects on filterability and implications for microangiopathy. Proc Natl Acad Sci U S A (1989) 1.02
Prolonged depletion of guanosine triphosphate induces death of insulin-secreting cells by apoptosis. Endocrinology (1998) 1.00
Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci (2001) 1.00
Ceramide induces mitochondrial abnormalities in insulin-secreting INS-1 cells: potential mechanisms underlying ceramide-mediated metabolic dysfunction of the beta cell. Apoptosis (2005) 0.99
Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs. Diabetologia (1994) 0.98
Evidence for glucose-responsive and -unresponsive pools of phospholipid in pancreatic islets. J Biol Chem (1985) 0.98
Distribution of aldose reductase in ocular tissues. Exp Eye Res (1981) 0.98
Hyperglycemia as a cause of diabetic retinopathy. Metabolism (1986) 0.96
Glut1 and glut3 expression, but not capillary density, is increased by cobalt chloride in rat cerebrum and retina. Brain Res Mol Brain Res (1999) 0.95
Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases. Diabetes (1998) 0.94
Abnormalities of retinal metabolism in diabetes or galactosemia. II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy. Curr Eye Res (1994) 0.93
Small elevations of glucose concentration redirect and amplify the synthesis of guanosine 5'-triphosphate in rat islets. J Clin Invest (1993) 0.92
Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. Diabetes (2000) 0.91
Non-uniform distribution of lesions and biochemical abnormalities within the retina of diabetic humans. Curr Eye Res (2003) 0.90
Characterization of prenylcysteine methyltransferase in insulin-secreting cells. Biochem J (1996) 0.89
Immunohistochemical distribution of aldose reductase. Histochem J (1982) 0.89
Calcium-calmodulin-dependent myosin phosphorylation by pancreatic islets. Diabetes (1982) 0.86
Secretagogue-responsive and -unresponsive pools of phosphatidylinositol in pancreatic islets. Arch Biochem Biophys (1986) 0.86
Corneal endothelial changes in diabetic dogs. Curr Eye Res (1985) 0.85
Hexitol production by canine retinal microvessels. Invest Ophthalmol Vis Sci (1985) 0.84
Omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic mice. Nutr Diabetes (2012) 0.84
Regulatory roles for histone deacetylation in IL-1beta-induced nitric oxide release in pancreatic beta-cells. J Cell Mol Med (2007) 0.83
A defect late in stimulus-secretion coupling impairs insulin secretion in Goto-Kakizaki diabetic rats. Diabetes (1999) 0.83
Positive modulation by Ras of interleukin-1beta-mediated nitric oxide generation in insulin-secreting clonal beta (HIT-T15) cells. Biochem Pharmacol (2001) 0.83
Diabetes-induced metabolic abnormalities in myocardium: effect of antioxidant therapy. Free Radic Res (2000) 0.83
The effect of elevated extracellular glucose on migration, adhesion and proliferation of SV40 transformed human corneal epithelial cells. Curr Eye Res (1998) 0.82
Retina accumulates more glucose than does the embryologically similar cerebral cortex in diabetic rats. Diabetologia (2000) 0.82
IL-1beta-induced nitric oxide release from insulin-secreting beta-cells: further evidence for the involvement of GTP-binding proteins. Diabetes Metab (2002) 0.81
Phospholipid methyltransferase activity in pancreatic islets: activation by calcium. Arch Biochem Biophys (1985) 0.81
Inosine monophosphate dehydrogenase: A molecular switch integrating pleiotropic GTP-dependent beta-cell functions. Proc Assoc Am Physicians (1999) 0.80
Glycation of calmodulin: chemistry and structural and functional consequences. Biochemistry (1989) 0.80
NF-κB subunits are differentially distributed in cells of lumbar dorsal root ganglia in naïve and diabetic rats. Neurosci Lett (2010) 0.80
Capillary basement membrane in retina, kidney, and muscle of diabetic dogs and galactosemic dogs and its response to 5 years aldose reductase inhibition. J Diabetes Complications (1993) 0.79
Abnormalities of retinal metabolism in diabetes or experimental galactosemia. VI. Comparison of retinal and cerebral cortex metabolism, and effects of antioxidant therapy. Free Radic Biol Med (1999) 0.79
Enzymes of phospholipid metabolism in rat pancreatic islets: subcellular distribution and the effect of glucose and calcium. J Cell Biochem (1986) 0.78
Evidence for calcium enhanced phosphorylation of pyruvate kinase by pancreatic islets. Mol Cell Biochem (1985) 0.78
Stimulation of phospholipid methylation by glucose in pancreatic islets. Biochem Biophys Res Commun (1984) 0.77
Functional inactivation by interleukin-1beta of glyceraldehyde-3-phosphate dehydrogenase in insulin-secreting cells. Apoptosis (2002) 0.77
Protein phosphorylation in pancreatic islets: evidence for separate Ca2+ and cAMP-enhanced phosphorylation of two 57,000 Mr proteins. Biochem Biophys Res Commun (1984) 0.77
Is diabetic retinopathy preventable? Int Ophthalmol Clin (1987) 0.77
Kidney morphology in experimental hyperglycemia. Diabetes (1987) 0.77
GTP-binding protein-independent potentiation by mastoparan of IL-1beta-induced nitric oxide release from insulin-secreting HIT-T15 cells. Apoptosis (2004) 0.77
Diabetic retinopathy: is it a consequence of hyperglycaemia? Diabet Med (1985) 0.77
Evidence for phosphorylation of pancreatic islet pyruvate kinase. Metabolism (1985) 0.77
Calcium-activated factors in pancreatic islets that inhibit actin polymerization. Arch Biochem Biophys (1982) 0.77
Glucose-induced, calcium-mediated protein phosphorylation in intact pancreatic islets. Arch Biochem Biophys (1984) 0.77
Evidence of a glycemic threshold for the formation of pentosidine in diabetic dog lens but not in collagen. Diabetes (1996) 0.75
Hyperglycemia and development of glomerular pathology: diabetes compared with galactosemia. Kidney Int (1989) 0.75
Microvascular metabolism in diabetes. Metabolism (1986) 0.75
Retinopathy and tissue hexose in drug-treated animals. Arch Ophthalmol (1998) 0.75
Activation of pancreatic islet myosin ATPase by ATP and actin. Biochem Med (1985) 0.75
Comment on the DCCT report. Diabetes Control and Complications Trial. Diabetes (1996) 0.75
Biochemical and anatomic evidence for renal tubule hypermetabolism and hypertrophy in long-standing experimental diabetes mellitus. Contrib Nephrol (1991) 0.75
Platelet aggregation in experimental diabetes and experimental galactosemia. Diabetes (1984) 0.75
Effect of substance P, insulin-like growth factor-1 and vasoactive intestinal polypeptide on corneal re-epithelialization in galactosemic rats. Curr Eye Res (1998) 0.75
Non-enzymatic glycation and protein recognition. Prog Clin Biol Res (1989) 0.75
Abnormal amino acid concentrations in plasma and urine of experimentally diabetic dogs. Res Exp Med (Berl) (1983) 0.75
Nerve conduction velocity in dogs is reduced by diabetes and not by galactosemia. Metabolism (1990) 0.75
Erythrocyte sodium-potassium ATPase activity and thiol metabolism in genetically hyperglycemic mice. Metabolism (1992) 0.75